# MS DCF Valuation — Investment Banking Valuation Memo
**Date: 2026-09-07 (Monday, Labor Day — markets closed all session) ~14:15 ET — price-roll update only, no rebuild triggered on any name; XLE's oil-adjusted composite explicitly re-checked against the weekend/Monday Hormuz escalation per GS's own request.**

*Persona: VP-level valuation coverage for the "Claude Robinhood Trader" experiment. Coverage this run: (1) NVDA, (2) OMCL, (3) VTI, (4) VXUS, (5) XLE, (6) GEHC — all six current holdings per state.md (prices unchanged since Friday 2026-09-04 ~15:36 ET close; NYSE/Nasdaq/bond markets closed today for Labor Day, confirmed via WebSearch, reopening Tuesday 9/8 09:30 ET). GS's 2026-09-07 ~13:45 ET report's #1 pick is XLE — already a holding, so no separate non-holding section is needed this run (unlike 9/4, when the #1 pick, IONQ, was not held). Per rule 4, live Robinhood-verified prices from state.md take precedence over WebSearch; state.md itself confirms every quote today is a verbatim carry-forward of Friday's closing print (`last_trade_price` timestamps still read 2026-09-04), so this desk treats Friday's close as the governing price set rather than re-sourcing intraday levels that do not exist today.*

---

## Verdicts (top line)

| Ticker | Current Price | DCF Fair Value (base case) | Verdict |
|---|---|---|---|
| **NVDA** | $229.85 (state.md, Fri 9/4 close, -0.61% vs. Thu) | **~$206.2** (WACC 11%, g 3% — unchanged since 8/27) | **MILDLY OVERVALUED — ~10.3% downside to base case**, narrowed slightly from 9/4's ~11.5% as NVDA gave back some of Friday's intraday rally into the close. Still within ~2.4% of the bull case ($235.5). |
| **OMCL** | $34.21 (state.md, Fri close, -1.75%) | ~$53.89 (WACC 9%, g 3%, unchanged since 7/30) | **UNDERVALUED — ~57.5% upside to DCF fair value**, the widest discount this desk has recorded on this name to date. |
| **VTI** | $379.60 (-0.35%) | N/A — no single-company DCF applies | **NOT APPLICABLE / HOLD BY CONSTRUCTION.** Unchanged. |
| **VXUS** | $88.31 (+0.39%) | N/A — no single-company DCF applies | **NOT APPLICABLE / HOLD BY CONSTRUCTION.** Unchanged. |
| **XLE** | $64.055 (-0.87%) | Composite (oil-adjusted) fair value ≈ **$53.2/sh** (equity-comp leg essentially flat; see §5 for why this run's oil spike is *not* yet flowing through this stopgap model) | **OVERVALUED, gap ≈ -17.0%**, widened slightly from 9/4's -16.4% on the modest further pullback in the ETF itself. **Do not add — and this desk is flagging its own model as likely stale here, see below.** |
| **GEHC** | $68.92 (-1.15% vs. 9/3 close, +0.33% vs. $68.69 entry cost) | ~$70.2 (WACC 8.5%, g 3%, unchanged since 8/21) | **MILDLY UNDERVALUED — ~1.9% upside to base case**, essentially flat vs. 9/4's ~1.8% read. |

**Bottom line for the trader:** Nothing to rebuild — markets have been closed since Friday's 15:36 ET print, and Friday's own close is confirmed (via state.md's own live Robinhood pull today) to be identical to today's quotes, so every fair-value gap above is a mechanical roll of unchanged models against the same prices this desk already valued Friday. The one item genuinely worth flagging is XLE: WTI and Brent have kept climbing through the weekend and into today (Brent now testing ~$97.50, WTI above $92 — a further leg beyond even GS's own weekend read of Brent ~$95.05/WTI ~$90.38), while CVX itself — the equity-comp leg this desk's stopgap composite model actually runs off — is essentially flat at ~$208.76, barely off Friday's range. That divergence means this desk's ~$53.2 composite fair value is almost certainly understating the read-through of the actual commodity move, because the model's only live input (the equity comp) hasn't caught up to the commodity anchor yet. This desk is naming that gap explicitly rather than quietly carrying forward a number it has reason to believe is stale. NVDA, OMCL, and GEHC are unchanged, mechanical rolls — no structural news found on any of the three via a fresh WebSearch sweep this run (NVDA: Hugging Face deal fully digested, a new $0.25 dividend announced with a 9/10 ex-date, immaterial to this model; OMCL: nothing beyond the already-known Q2 print and 10/29 next-earnings date; GEHC: nothing beyond the already-known CFO transition (9/14) and Wells Fargo conference (9/9), plus a minor CE Mark approval (Photonova Spectra CT) and a Vivid ultrasound refresh, neither large enough to move the FCF build).

---

## 1. NVIDIA (NVDA) — price-roll update, model unchanged

Price $229.85 (state.md, Fri 9/4 15:36 ET close, -0.61% vs. Thursday's close). Fresh WebSearch this run: NVDA closed Friday at $230.36 per outside sources (a de minimis ~$0.51 discrepancy vs. state.md's Robinhood-sourced $229.85, immaterial and resolved in favor of the Robinhood figure per rule 4), just shy of its own May 14 record ($235.74). New items found — a $0.25/share cash dividend (ex-date 9/10) and continued digestion of the Hugging Face acquisition (~$13B, signed 9/2) — are both immaterial to a DCF sized at this scale. No rebuild triggered.

| Scenario | Fair value/share | vs. $229.85 live price |
|---|---|---|
| Bear (guide disappoints, WACC 12%, g 2%) | $124.3 | **-45.9% (sharply overvalued)** |
| Base (partial credit, WACC 11%, g 3%) | **$206.2** | **-10.3% (mildly overvalued)** |
| Bull (full credit to mgmt's own guide, WACC 11%, g 3%) | $235.5 | **+2.5% (still the closest read to fair value on the book)** |

**Sensitivity table (WACC × terminal g, base-case cash-flow path):**
| WACC \\ Terminal g | 2% | 3% | 4% |
|---|---|---|---|
| 10% | $218.9 | $230.4 | $243.6 |
| **11% (base)** | $196.1 | **$206.2** | $217.6 |
| 12% | $177.4 | $186.1 | $195.9 |

### Verdict: **MILDLY OVERVALUED, gap narrowed to ~10.3% as Friday's close gave back some of the day's intraday rally**
Hold, no add, no trim from this desk's chair. Per state.md's Friday close, NVDA sits at ~12.68% equity/~11.19% pool — comfortably below the 18-20% single-name trigger; NVDA+OMCL combined ~20.78%, buffer ~4.22pp to the 25% trigger.

### Key assumptions that could break this model (unchanged from 8/27)
- Upside break: the 70% FY28 guide proves genuinely supply-constrained (a floor, not a ceiling).
- Downside break: AVGO/hyperscaler custom-silicon competition erodes the 75% gross-margin assumption in years 3-5; the NVDA CDS record (still unresolved via WebSearch after 11+ cycles per BW) sustaining a confirmed close above 82bps would argue for the bear-case WACC.
- Downside break: any plateau in AI capex growth collapses the bull/base case toward the bear case fast — still worth watching given how close price sits to the bull-case ceiling.

---

## 2. Omnicell (OMCL) — price-roll update, model unchanged, discount at its widest recorded level

Price $34.21 (state.md, Fri 9/4 15:36 ET close, -1.75% vs. Thursday). Fresh WebSearch this run found nothing beyond the already-known Q2 print (EPS $0.94 vs. $0.44 est.) and the confirmed 10/29 next-earnings date.

Base case fair value **$53.89** (WACC 9%, g 3% — unchanged since 7/30) vs. $34.21 implies **~57.5% upside** — the widest gap this desk has recorded on this name since coverage began, edging out 9/4's ~56.8%.

### Verdict: **UNDERVALUED — still the widest mispricing on the book, still gated**
No fresh catalyst to act on (rule 1); the OMCL DCA accumulated-profit gate (per state.md, ~$1.053 of the $2.50 threshold as of today's market-closed check, ~$1.447 still required) remains the operative timing mechanism, not this desk's valuation call, which has read undervalued consistently since 7/30.

### Key assumptions that could break this model (unchanged)
- Upside break: the softer Q3/bookings guide proves conservative rather than a genuine slowdown — would push fair value toward $56-60+.
- Downside break: continued high-amplitude, no-catalyst price action is itself a signal of unusually high name-specific volatility relative to this book's other holdings — an argument for sizing discipline, not for revising this desk's valuation call.

---

## 3. Vanguard Total Stock Market ETF (VTI) — unchanged, brief refresh only
No change to the standing "not applicable" treatment. $379.60 (-0.35% Fri). This desk has no fair-value view on VTI and defers entirely to BR/BW on sizing and drift-band status.

## 4. Vanguard Total International Stock ETF (VXUS) — unchanged, brief refresh only
No change to the standing "not applicable" treatment. $88.31 (+0.39% Fri). No fair-value case to add or trim. Defer to BR/BW.

---

## 5. Energy Select Sector SPDR (XLE) — oil-adjusted composite re-checked against the weekend escalation; flagging the model as likely understating the move

### Why this section gets more than a mechanical roll this run
GS's 2026-09-07 report explicitly asked this desk not to reuse the pre-weekend oil assumption when next touching this model: "the move from ~$86 to ~$90-95 (WTI/Brent, post-strike) is large enough that a same-day-appearing 'current' DCF could still be built on a stale input if the oil price feeding it wasn't refreshed." This desk is honoring that ask directly rather than letting it sit as an unanswered escalation for a second cycle.

### What actually moved, and what didn't
Fresh WebSearch this run: **Brent is now testing ~$97.50/bbl and WTI is trading above $92/bbl** — a further leg beyond even GS's own weekend read (Brent ~$95.05, WTI ~$90.38) and well beyond the ~$95.2-96.9 Brent range this desk's 9/4 composite was built on. Tanker traffic through the Strait has reportedly fallen to its lowest level since May. **CVX itself, the equity-comp leg this desk's stopgap composite actually runs off, is trading ~$208.76 — essentially flat versus the ~$205-211 range already used in Friday's build**, and still below its own 9/2 all-time closing high of $211.78.

That is a genuine divergence worth naming plainly: the commodity anchor has moved meaningfully further (Brent +2.5-3pts, WTI +2pts vs. this desk's Friday inputs), while the actual input variable feeding this desk's composite (CVX price) has not moved at all. Because this model is, by this desk's own repeated admission, an **equity-comp-leg-only stopgap** (not a ground-up oil-price-to-cash-flow rebuild), it mechanically produces an unchanged fair value (~$53.2/sh) even though the underlying commodity thesis has strengthened further. **This desk is not going to manufacture a precision-looking new number by hand-adjusting the composite off an oil beta this model was never built to carry — that would be worse than being honest about the gap.** The correct fix, flagged for a fourth-plus consecutive cycle now, remains a full ground-up composite rebuild (last done 7/24-7/28); until that happens, treat the ~$53.2 figure as a **floor, not a best estimate**, on days when oil moves and the energy-major equity comps have not yet caught up.

Applied to XLE's Friday close ($64.055, -0.87%), the mechanical gap reads **~-17.0%** (overvalued), marginally wider than 9/4's -16.4% purely on the ETF's own modest pullback — not a fresh anchor read, and, per the above, likely understating how much the fundamental case for holding XLE as a hedge has actually strengthened since Friday.

### Verdict: **OVERVALUED on this desk's current model — but the model itself is flagged as stale on the input side, not the output**
No trim (the Hormuz standoff has escalated, not de-escalated — the confirming case for holding XLE as a hedge, not a reason to touch it), no add (this desk's own number still reads overvalued, and rule 5's discipline doesn't bend because the direction of the miss is inconvenient). Do-not-add stance unchanged. **Standing recommendation, escalated**: the ground-up composite rebuild is now overdue by six weeks and this desk's own admission that CVX hasn't caught up to a ~$92-97 oil tape is the clearest evidence yet that the stopgap has run past its useful life — this should be the next full rebuild this desk does, ahead of any further AVGO or other backlog item.

### Key assumptions that could break this model
- Upside break (narrows the overvaluation further, or could flip the read): if CVX/XOM re-rate to catch up with the current $92-97 oil tape rather than the ~$208 level this model still carries, or if GS revises its own $80 Q4'26 Brent house forecast upward given the sustained spot climb, this desk would follow with a genuine anchor revision.
- Downside break: OPEC's 2026 demand-cut framing, if the forward anchor moves at all, would argue for moving it down, not up — unchanged this cycle, and increasingly hard to square with the live tape.

---

## 6. GE HealthCare (GEHC) — price-roll update, model unchanged, cushion essentially flat

Price $68.92 (state.md, Fri 9/4 15:36 ET close, -1.15% vs. 9/3 close, but +0.33% vs. the $68.69 entry cost — still a small net gain on the position, sixth session held). Fresh WebSearch this run found nothing structurally new: the already-known Grogan CFO transition (effective 9/14, one week out) and Wells Fargo Health Conference appearance (9/9, two days out) remain the near-term calendar items; a CE Mark approval for the Photonova Spectra CT system and a Vivid cardiovascular ultrasound refresh (unveiled 8/28) are real but immaterial to a five-year FCF build at this company's scale.

Base case fair value **$70.2/sh** (WACC 8.5%, g 3%, unchanged since 8/21) vs. $68.92 implies **~1.9% upside**, essentially flat vs. 9/4's ~1.8% read.

### Verdict: **MILDLY UNDERVALUED — reading holds, still not a sizing signal**
Hold, no add from this desk's chair — a ~1.9% DCF discount on a name this desk has always described as "assumption-dependent" is not a green light for further sizing on an already-at-target quarter-size satellite position.

### Key assumptions that could break this model (unchanged from 8/21)
- Upside break: FCF conversion improving toward ~10% faster than modeled (the central assumption behind this desk's fair-value line) would push fair value higher.
- Downside break: net debt sourced worse than BW's 10-Q-corrected ~$8.0B (this desk's illustrative $7.5B was already ~$0.5B optimistic per BW's own correction) would pull fair value down further; a backlog/book-to-bill reversal would be a genuine structural break, not modeled here.

---

## Cross-check with GS screener (analysts/gs-stock-screener.md, 2026-09-07 report)
GS's #1 pick this cycle is XLE — already held, so no separate non-holding valuation is needed. GS's own framing (Tuesday's open is the first live test of how much of the weekend escalation the market has priced, and an explicit ask that this desk not reuse the pre-weekend oil assumption) is directly addressed in §5 above: this desk agrees the commodity move is real and likely under-reflected in its own composite, while declining to hand-wave a precision number the underlying stopgap model was never built to produce. No disagreement with GS's OXY veto reaffirmation, CRWD/AVGO rule-6-gate escalations (both remain outside this desk's coverage list until a first build is undertaken — noted as the standing process gap, not something this run resolves), or its MU/FRO hard-pass reads (both consistent with this desk's own prior DCF vetoes).

## Explicit read on trader's current positions (all six: NVDA, OMCL, VTI, VXUS, XLE, GEHC)
**NVDA**: hold, no add, no trim — base-case DCF gap narrowed slightly to ~10.3% overvalued on Friday's close; price still within ~2.5% of this desk's bull case.
**OMCL**: hold, no add from this desk's chair — DCF discount at its widest recorded level (~57.5%). The DCA plan's own profit-threshold gate remains the actual timing mechanism.
**VTI / VXUS**: hold, no valuation view — diversified core-sleeve holdings, not DCF calls. Defer to BR/BW on drift-band status.
**XLE**: hold, no trim, no add on this desk's current model — but this desk is explicitly flagging that model as likely stale on the input side given oil has moved further than the equity comp (CVX) has caught up to; a full ground-up rebuild is now this desk's top standing priority.
**GEHC**: hold, no add — mildly-undervalued read holds essentially flat (~+1.9%). Not a sizing signal for a position already at its intended quarter-size weight.

---

Sources:
- [Check out Chevron Corporation's stock price (CVX) in real time (CNBC)](https://www.cnbc.com/quotes/CVX)
- [Chevron Stock Is Up 36% in 2026. Here's Why Analysts See a $251 Target (TIKR)](https://www.tikr.com/blog/chevron-stock-is-up-36-in-2026-heres-why-analysts-see-a-251-target)
- [Brent Crude Oil Futures Contracts (Oilprice.com)](https://oilprice.com/futures/brent/)
- [Brent Crude Oil Price Surges Past $92 as Hormuz Clash Escalates (Vantage Markets)](https://www.vantagemarkets.com/market-analysis/brent-crude-oil-price-surges-hormuz-clash-wti-ukousd-usousd-august-31-september-4-2026/)
- [Oil prices drop slightly as Mideast war enters Day 14 amid Iran's Hormuz threats (Gulf News)](https://gulfnews.com/amp/story/business%2Fenergy%2Foil-prices-drop-slightly-as-mideast-war-enters-day-14-amid-irans-hormuz-threats-diplomacy-to-show-a-way-out-1.500472825)
- [Nvidia stock moves closer to all-time high (Yahoo Finance)](https://finance.yahoo.com/markets/article/nvidia-stock-moves-closer-to-all-time-high-193309793.html)
- [GE HealthCare stock holds steady as investors watch margins and imaging demand (ad-hoc-news.de)](https://www.ad-hoc-news.de/boerse/news/corporate-news/ge-healthcare-stock-holds-steady-as-investors-watch-margins-and-imaging/70060271)
- [Investors Overview (GE HealthCare)](https://investor.gehealthcare.com/)
- [Omnicell, Inc. (OMCL) Latest Stock News & Headlines (Yahoo Finance)](https://finance.yahoo.com/quote/OMCL/news/)
- Internal: trading-experiment/state.md (2026-09-07 ~13:36 ET market-closed run notes, and the 9/4 15:36 ET close it carries forward), analysts/gs-stock-screener.md (9/7 ~13:45 ET report), analysts/bw-risk-assessment.md (9/4 ~14:41 ET report), analysts/ms-dcf-valuation.md (9/4 report, this desk's prior report — full detail via git history)
